Jefferies Affirms Buy Rating for Lumexa Imaging (LMRI) Following Site Visit

April 14, 2026 3:10 PM

Jefferies analyst Brian Tanquilut reiterated a Buy rating and $23.00 price target on Lumexa Imaging Holdings (NASDAQ: LMRI)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found